Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.06%
#3 CoW Protocol CoW Protocol +41.78%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.87%
#6 Codatta Codatta +21.56%
#7 Walrus Walrus +20.27%
#8 Enso Enso +18.27%
#9 The Black Bull The Black Bull +16.62%
#10 Tutorial Tutorial +14.28%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
주식 순위 #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
주가
$0.30221445
마지막 동기화: 2023-05-22
시가총액
$2.49M
변동 (1일)
-0.10%
변동 (1년)
0.00%
국가
FR
거래 Lysogene S.A. (LYS)

카테고리

Healthcare
Lysogene S.A. (LYS)의 주식 분할 이력
Lysogene S.A. 주식 (심볼: LYS)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 15, 2026에 발생했습니다.
Aug 15, 2026 이전에 매수한 LYS 주식 1주는 현재 0주의 LYS 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE